Selected research
Industry Growth & Trends
Global Topical Steroids Industry Growth and Trends Forecast to 2032
Market perspective
The global Topical Steroids market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Topical Steroids is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Topical Steroids is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Topical Steroids is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Topical Steroids include Abbott, Sanofi, Novartis, Merck, Roche, Eli Lilly, Pfizer, Glaxosmithkline and Bayer, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Topical Steroids market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Topical Steroids market size, estimates, and forecasts are presented in terms of sales volume (k tons) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Topical Steroids market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Topical Steroids.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Topical Steroids market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Topical Steroids Market by Company
Abbott
Sanofi
Novartis
Merck
Roche
Eli Lilly
Pfizer
Glaxosmithkline
Bayer
Taro Pharmaceuticals U.S.A.
Taro Pharmaceuticals
Pure Tek
Nu Care Pharmaceuticals
Galderma
Arbor Pharmaceuticals
Aqua Pharmaceuticals
Apotex
Topical Steroids Segment by Type
Class III
Class II
Class IV
Class I
Class VII
Class VI
Class V
Topical Steroids Segment by Application
Treatment of Dermatitis
Treatment of Rash
Treatment of Eczema
Topical Steroids Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Topical Steroids market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Topical Steroids and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Topical Steroids.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Topical Steroids manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Topical Steroids in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Class III
- Class II
- Class IV
- Class I
- Class VII
- Class VI
- Class V
Applications
- Treatment of Dermatitis
- Treatment of Rash
- Treatment of Eczema
Companies covered
- Abbott
- Sanofi
- Novartis
- Merck
- Roche
- Eli Lilly
- Pfizer
- Glaxosmithkline
- Bayer
- Taro Pharmaceuticals U.S.A.
- Taro Pharmaceuticals
- Pure Tek
- Nu Care Pharmaceuticals
- Galderma
- Arbor Pharmaceuticals
- Aqua Pharmaceuticals
- Apotex
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Topical Steroids Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Topical Steroids Sales Estimates and Forecasts (2021-2032)
- 1.3 Topical Steroids Market by Type
- 1.3.1 Class III
- 1.3.2 Class II
- 1.3.3 Class IV
- 1.3.4 Class I
- 1.3.5 Class VII
- 1.3.6 Class VI
- 1.3.7 Class V
- 1.4 Global Topical Steroids Market Size by Type
- 1.4.1 Global Topical Steroids Market Size Overview by Type (2021-2032)
- 1.4.2 Global Topical Steroids Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Topical Steroids Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Topical Steroids Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Topical Steroids Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Topical Steroids Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Topical Steroids Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Topical Steroids Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Topical Steroids Industry Trends
- 2.2 Topical Steroids Industry Drivers
- 2.3 Topical Steroids Industry Opportunities and Challenges
- 2.4 Topical Steroids Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Topical Steroids Revenue (2021-2026)
- 3.2 Global Top Players by Topical Steroids Sales (2021-2026)
- 3.3 Global Top Players by Topical Steroids Price (2021-2026)
- 3.4 Global Topical Steroids Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Topical Steroids Major Company Production Sites & Headquarters
- 3.6 Global Topical Steroids Company, Product Type & Application
- 3.7 Global Topical Steroids Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Topical Steroids Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Topical Steroids Players Market Share by Revenue in 2025
- 3.8.3 2025 Topical Steroids Tier 1, Tier 2, and Tier 3
4 Topical Steroids Regional Status and Outlook
- 4.1 Global Topical Steroids Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Topical Steroids Historic Market Size by Region
- 4.2.1 Global Topical Steroids Sales in Volume by Region (2021-2026)
- 4.2.2 Global Topical Steroids Sales in Value by Region (2021-2026)
- 4.2.3 Global Topical Steroids Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Topical Steroids Forecasted Market Size by Region
- 4.3.1 Global Topical Steroids Sales in Volume by Region (2027-2032)
- 4.3.2 Global Topical Steroids Sales in Value by Region (2027-2032)
- 4.3.3 Global Topical Steroids Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Topical Steroids by Application
- 5.1 Topical Steroids Market by Application
- 5.1.1 Treatment of Dermatitis
- 5.1.2 Treatment of Rash
- 5.1.3 Treatment of Eczema
- 5.2 Global Topical Steroids Market Size by Application
- 5.2.1 Global Topical Steroids Market Size Overview by Application (2021-2032)
- 5.2.2 Global Topical Steroids Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Topical Steroids Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Topical Steroids Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Topical Steroids Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Topical Steroids Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Topical Steroids Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Topical Steroids Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Abbott
- 6.1.1 Abbott Company Information
- 6.1.2 Abbott Business Overview
- 6.1.3 Abbott Topical Steroids Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Abbott Topical Steroids Product Portfolio
- 6.1.5 Abbott Recent Developments
- 6.2 Sanofi
- 6.2.1 Sanofi Company Information
- 6.2.2 Sanofi Business Overview
- 6.2.3 Sanofi Topical Steroids Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Sanofi Topical Steroids Product Portfolio
- 6.2.5 Sanofi Recent Developments
- 6.3 Novartis
- 6.3.1 Novartis Company Information
- 6.3.2 Novartis Business Overview
- 6.3.3 Novartis Topical Steroids Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Novartis Topical Steroids Product Portfolio
- 6.3.5 Novartis Recent Developments
- 6.4 Merck
- 6.4.1 Merck Company Information
- 6.4.2 Merck Business Overview
- 6.4.3 Merck Topical Steroids Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Merck Topical Steroids Product Portfolio
- 6.4.5 Merck Recent Developments
- 6.5 Roche
- 6.5.1 Roche Company Information
- 6.5.2 Roche Business Overview
- 6.5.3 Roche Topical Steroids Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Roche Topical Steroids Product Portfolio
- 6.5.5 Roche Recent Developments
- 6.6 Eli Lilly
- 6.6.1 Eli Lilly Company Information
- 6.6.2 Eli Lilly Business Overview
- 6.6.3 Eli Lilly Topical Steroids Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Eli Lilly Topical Steroids Product Portfolio
- 6.6.5 Eli Lilly Recent Developments
- 6.7 Pfizer
- 6.7.1 Pfizer Company Information
- 6.7.2 Pfizer Business Overview
- 6.7.3 Pfizer Topical Steroids Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 Pfizer Topical Steroids Product Portfolio
- 6.7.5 Pfizer Recent Developments
- 6.8 Glaxosmithkline
- 6.8.1 Glaxosmithkline Company Information
- 6.8.2 Glaxosmithkline Business Overview
- 6.8.3 Glaxosmithkline Topical Steroids Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 Glaxosmithkline Topical Steroids Product Portfolio
- 6.8.5 Glaxosmithkline Recent Developments
- 6.9 Bayer
- 6.9.1 Bayer Company Information
- 6.9.2 Bayer Business Overview
- 6.9.3 Bayer Topical Steroids Sales, Revenue and Gross Margin (2021-2026)
- 6.9.4 Bayer Topical Steroids Product Portfolio
- 6.9.5 Bayer Recent Developments
- 6.10 Taro Pharmaceuticals U.S.A.
- 6.10.1 Taro Pharmaceuticals U.S.A. Company Information
- 6.10.2 Taro Pharmaceuticals U.S.A. Business Overview
- 6.10.3 Taro Pharmaceuticals U.S.A. Topical Steroids Sales, Revenue and Gross Margin (2021-2026)
- 6.10.4 Taro Pharmaceuticals U.S.A. Topical Steroids Product Portfolio
- 6.10.5 Taro Pharmaceuticals U.S.A. Recent Developments
- 6.11 Taro Pharmaceuticals
- 6.11.1 Taro Pharmaceuticals Company Information
- 6.11.2 Taro Pharmaceuticals Business Overview
- 6.11.3 Taro Pharmaceuticals Topical Steroids Sales, Revenue and Gross Margin (2021-2026)
- 6.11.4 Taro Pharmaceuticals Topical Steroids Product Portfolio
- 6.11.5 Taro Pharmaceuticals Recent Developments
- 6.12 Pure Tek
- 6.12.1 Pure Tek Company Information
- 6.12.2 Pure Tek Business Overview
- 6.12.3 Pure Tek Topical Steroids Sales, Revenue and Gross Margin (2021-2026)
- 6.12.4 Pure Tek Topical Steroids Product Portfolio
- 6.12.5 Pure Tek Recent Developments
- 6.13 Nu Care Pharmaceuticals
- 6.13.1 Nu Care Pharmaceuticals Company Information
- 6.13.2 Nu Care Pharmaceuticals Business Overview
- 6.13.3 Nu Care Pharmaceuticals Topical Steroids Sales, Revenue and Gross Margin (2021-2026)
- 6.13.4 Nu Care Pharmaceuticals Topical Steroids Product Portfolio
- 6.13.5 Nu Care Pharmaceuticals Recent Developments
- 6.14 Galderma
- 6.14.1 Galderma Company Information
- 6.14.2 Galderma Business Overview
- 6.14.3 Galderma Topical Steroids Sales, Revenue and Gross Margin (2021-2026)
- 6.14.4 Galderma Topical Steroids Product Portfolio
- 6.14.5 Galderma Recent Developments
- 6.15 Arbor Pharmaceuticals
- 6.15.1 Arbor Pharmaceuticals Company Information
- 6.15.2 Arbor Pharmaceuticals Business Overview
- 6.15.3 Arbor Pharmaceuticals Topical Steroids Sales, Revenue and Gross Margin (2021-2026)
- 6.15.4 Arbor Pharmaceuticals Topical Steroids Product Portfolio
- 6.15.5 Arbor Pharmaceuticals Recent Developments
- 6.16 Aqua Pharmaceuticals
- 6.16.1 Aqua Pharmaceuticals Company Information
- 6.16.2 Aqua Pharmaceuticals Business Overview
- 6.16.3 Aqua Pharmaceuticals Topical Steroids Sales, Revenue and Gross Margin (2021-2026)
- 6.16.4 Aqua Pharmaceuticals Topical Steroids Product Portfolio
- 6.16.5 Aqua Pharmaceuticals Recent Developments
- 6.17 Apotex
- 6.17.1 Apotex Company Information
- 6.17.2 Apotex Business Overview
- 6.17.3 Apotex Topical Steroids Sales, Revenue and Gross Margin (2021-2026)
- 6.17.4 Apotex Topical Steroids Product Portfolio
- 6.17.5 Apotex Recent Developments
7 North America by Country
- 7.1 North America Topical Steroids Sales by Country
- 7.1.1 North America Topical Steroids Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Topical Steroids Sales by Country (2021-2026)
- 7.1.3 North America Topical Steroids Sales Forecast by Country (2027-2032)
- 7.2 North America Topical Steroids Market Size by Country
- 7.2.1 North America Topical Steroids Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Topical Steroids Market Size by Country (2021-2026)
- 7.2.3 North America Topical Steroids Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Topical Steroids Sales by Country
- 8.1.1 Europe Topical Steroids Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Topical Steroids Sales by Country (2021-2026)
- 8.1.3 Europe Topical Steroids Sales Forecast by Country (2027-2032)
- 8.2 Europe Topical Steroids Market Size by Country
- 8.2.1 Europe Topical Steroids Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Topical Steroids Market Size by Country (2021-2026)
- 8.2.3 Europe Topical Steroids Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Topical Steroids Sales by Country
- 9.1.1 Asia-Pacific Topical Steroids Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Topical Steroids Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Topical Steroids Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Topical Steroids Market Size by Country
- 9.2.1 Asia-Pacific Topical Steroids Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Topical Steroids Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Topical Steroids Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Topical Steroids Sales by Country
- 10.1.1 South America Topical Steroids Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Topical Steroids Sales by Country (2021-2026)
- 10.1.3 South America Topical Steroids Sales Forecast by Country (2027-2032)
- 10.2 South America Topical Steroids Market Size by Country
- 10.2.1 South America Topical Steroids Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Topical Steroids Market Size by Country (2021-2026)
- 10.2.3 South America Topical Steroids Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Topical Steroids Sales by Country
- 11.1.1 Middle East and Africa Topical Steroids Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Topical Steroids Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Topical Steroids Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Topical Steroids Market Size by Country
- 11.2.1 Middle East and Africa Topical Steroids Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Topical Steroids Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Topical Steroids Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Topical Steroids Value Chain Analysis
- 12.1.1 Topical Steroids Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Topical Steroids Production Mode & Process
- 12.2 Topical Steroids Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Topical Steroids Distributors
- 12.2.3 Topical Steroids Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst